[Cerebral perfusion and oxygen metabolism in Parkinson's disease: positron emission tomographic study using oxygen-15-labeled CO2 and O2]
- PMID: 9014453
[Cerebral perfusion and oxygen metabolism in Parkinson's disease: positron emission tomographic study using oxygen-15-labeled CO2 and O2]
Abstract
In many previous studies, positron emission tomography (PET) has been used to evaluate cerebral perfusion and oxygen metabolism in Parkinson's disease. In this article, these previous reports are reviewed together with our recent findings. Hypoperfusion and hypometabolism in parkinsonian brains reported previously seemed to be derived chiefly from psychiatric manifestations, including intellectual decline and depression. In our study on 34 patients with asymmetric symptoms, the blood flow and oxygen metabolism were significantly higher in the caudate head and putamen, contralateral to the predominant patient's symptoms, than in the opposite nuclei. The asymmetry in the perfusion and metabolism is clearer in the early stage of the disease or in patients without DOPA therapy. These findings suggest that the striatal dysfunction is caused by uninhibited activities, supersensitivities, or compensatory hyperactivities of the striatum.
Similar articles
-
[Clinical usefulness of positron emission tomography in the evaluation of regional cerebral blood flow and cerebral oxygen metabolism under glycerol and carbon dioxide loadings].Kaku Igaku. 1987 Feb;24(2):125-35. Kaku Igaku. 1987. PMID: 3112454 Japanese. No abstract available.
-
[18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].Nihon Rinsho. 1997 Jan;55(1):222-6. Nihon Rinsho. 1997. PMID: 9014454 Review. Japanese.
-
Cerebral hypoperfusion and hypometabolism with altered striatal signal intensity in chorea-acanthocytosis: a combined PET and MRI study.Mov Disord. 1998 Jan;13(1):100-7. doi: 10.1002/mds.870130121. Mov Disord. 1998. PMID: 9452334
-
[Positron emission tomography. A new measurement method for imaging of regional and biochemical parameters].Ugeskr Laeger. 1994 Oct 24;156(43):6341-7. Ugeskr Laeger. 1994. PMID: 7810006 Review. Danish.
-
Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.J Nucl Med. 1995 Jul;36(7):1226-31. J Nucl Med. 1995. PMID: 7790948
Cited by
-
Method for rapid MRI quantification of global cerebral metabolic rate of oxygen.J Cereb Blood Flow Metab. 2015 Oct;35(10):1616-22. doi: 10.1038/jcbfm.2015.96. Epub 2015 May 13. J Cereb Blood Flow Metab. 2015. PMID: 25966941 Free PMC article.
-
High temporal resolution MRI quantification of global cerebral metabolic rate of oxygen consumption in response to apneic challenge.J Cereb Blood Flow Metab. 2013 Oct;33(10):1514-22. doi: 10.1038/jcbfm.2013.110. Epub 2013 Jul 10. J Cereb Blood Flow Metab. 2013. PMID: 23838827 Free PMC article.
-
MRI estimation of global brain oxygen consumption rate.J Cereb Blood Flow Metab. 2010 Sep;30(9):1598-607. doi: 10.1038/jcbfm.2010.49. Epub 2010 Apr 21. J Cereb Blood Flow Metab. 2010. PMID: 20407465 Free PMC article.
-
Separation of cellular and BOLD contributions to T2* signal relaxation.Magn Reson Med. 2016 Feb;75(2):606-15. doi: 10.1002/mrm.25610. Epub 2015 Mar 10. Magn Reson Med. 2016. PMID: 25754288 Free PMC article.
-
Time-resolved MRI oximetry for quantifying CMRO(2) and vascular reactivity.Acad Radiol. 2014 Feb;21(2):207-14. doi: 10.1016/j.acra.2013.11.001. Acad Radiol. 2014. PMID: 24439334 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical